A recent study found that L-theanine had the therapeutic potential for metastatic prostate cancer (PCa), since L-theanine inhibited the epithelial-mesenchymal transition process of PCa by downregulating matrix metallopeptidase 9 (MMP9), N-cadherin, Vimentin, and Snail, and upregulating E-cadherin (70)
BPC 157 is a peptide originally derived from a protein in the stomach
Our data suggest that hypermethylation of the 25-hydroxylases, 1--hydroxylase enzymes, and the vitamin D receptor promoter, accompanied by hypomethylation of CYP24A1, leads to impaired expression and possibly a predisposition to VD deficiency/inadequacy
Our medical team carefully evaluates each patient to determine if this treatment aligns with their specific health needs and goals
The same needle, syringe and mixture is used for both subacromial and glenohumeral injections